Summary:
We are currently conducting a study for the treatment of active acnes. Subjects could be male or female, of any skin color. She/he must be between 18 and 55 years of age, and must have mild to moderate acne (15 or more inflammatory or non-inflammatory lesions).
The study will be conducted with the device Isolaz, which is a FDA cleared light device that treats the symptoms of acne. The study consists of up to 6 treatment visits, spaced 7 – 10 days apart, and two follow-up visits 1 month and 3 months after last treatment.
Qualified Participants Must:
• Not be using or have used Accutane in last 6 months
•
Meet other criteria as well
•
May be placed on additional topical regimen per study investigator’s discretion, which will be supplied to the subjects